MANDIE PITTMAN: Open Payments
NPI 1922571843 · MILTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 34 payments from 12 companies in 2025. Trend: 2023 $729 · 2024 $1,737 · 2025 $734
Food & beverage: $592Education: $142
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $138 |
| Janssen Biotech, Inc. | 4 | $105 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| GENZYME CORPORATION | 4 | $91 |
| ABBVIE INC. | 3 | $61 |
| PFIZER INC. | 2 | $50 |
| Galderma Laboratories, L.P. | 2 | $38 |
| UCB, Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
| Organon LLC | 5 | $31 |
Products named: DUPIXENT, OTEZLA, TREMFYA, CIBINQO, RINVOQ, NEMLUVIO, Bimzelx, EBGLYSS.
Industry payments across FL — which companies pay providers there.
